SAFETY AND EFFICACY OF FIT039 FOR VERRUCA VULGARIS: A PLACEBO-CONTROLLED, PHASE I/II RANDOMIZED CONTROLLED TRIAL

Safety and Efficacy of FIT039 for Verruca Vulgaris: A Placebo-Controlled, Phase I/II Randomized Controlled Trial

Trial design: Human papillomavirus infection causes verruca vulgaris.CDK9 Undercounter Dishwashers inhibitor FIT039 inhibits DNA virus proliferation in animal models.We conducted a multicenter, single-blind, placebo-controlled, randomized phase I/II clinical trial evaluating the safety and efficacy of FIT039 against verruca vulgaris.Methods: Target

read more


Bioelectrical Impedance Analysis Demonstrates Reliable Agreement with Dual-Energy X-ray Absorptiometry in Identifying Reduced Skeletal Muscle Mass in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease and Hypertension

Background/Objectives: Body composition (BC) affects the risk of developing metabolic dysfunction-associated steatotic liver disease (MASLD) and hypertension (HTN).Currently, dual-energy X-ray absorptiometry (DEXA) is considered the gold standard for assessing BC, even though it has some limitations, including immobility, ionizing radiation, and pa

read more